top of page
About Us
Journal
Platform
Pipeline
Engage
The Healing Project
Canurta Naturals USA
FutureBotanica 2024
Canurta Day '23
Contact
Canurta Journal
A collection of news, scientific papers and impact across industry, academia and events.
All Posts
Research
Events
Awards
News
Blog
Newsletter
Investigation of cannflavins as potential anti-SARS-CoV-2 agents
Jul 1, 2024
FutureBotanica Success, ALS Advocacy, and Canurta’s Expanding Scientific Presence in June 2024
Jun 28, 2024
The Antiatherogenic Potential of Flavonoids in Cardiovascular Health
Jun 24, 2024
Cannflavin A Displays Both a Hormetic and Neuroprotective Profile Against Alzheimer's Disease Progression
Jun 17, 2024
Canurta Showcases ALS and Neurodegenerative Research at Global Summits and Expands Scientific Leadership
May 31, 2024
Preclinical Research with a First-in-Class ALS Therapy Formulation
May 24, 2024
Reflecting on the ALS Drug Development Summit in Boston
May 24, 2024
FutureBotanica, 1871 Cannabis Innovation Lab's Pitch, and Bloom Burton & Co. Healthcare Investor Conference
Apr 30, 2024
The Neurotherapeutic Synergy of Botanical Bioactives
Apr 9, 2024
Grimsby Site Plan Approval, Algoma and BasgenBIO MOU, and New US Provisional with IPON Support
Mar 28, 2024
Chemistry and Activities of Cannflavins
Mar 19, 2024
Innovating Plant Flavonoid Production
Mar 14, 2024
Canurta Inc. Unveils Strategic Reorganization & Rebranding: Introducing Canurta Therapeutics and Canurta Naturals
Feb 8, 2024
Canurta Expands Global Reach Through Premier Conferences and Advances ALS Research
Jan 31, 2024
Canurta Advances ALS Research and Healthspan Innovation on the Global Stage
Dec 22, 2023
Canurta Showcases Healthy Aging Innovations on Global Stage and Advances Clinical Formulations
Nov 30, 2023
Can Cannflavins Treat Brain Cancer? Study Shows Molecules Have the Potential to Attack Tumour Cells
Nov 16, 2023
The Potential Benefits of Cannflavins for ALS Symptom Management
Nov 1, 2023
New Commercialization Partner, Our Recent Publication and Introducing FilingFlow
Oct 31, 2023
Exploring Canurta's Dual Inhibition Approach to Inflammation
Oct 25, 2023
bottom of page